» Articles » PMID: 36558489

The Impact of Serum Levels of Vitamin D3 and Its Metabolites on the Prognosis and Disease Severity of COVID-19

Overview
Journal Nutrients
Date 2022 Dec 23
PMID 36558489
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin D is among the increasingly consumed dietary supplements during the COVID-19 pandemic. It plays a regulatory role in the immune system and moderates the renin-angiotensin system, which is implicated in infection pathogenesis. However, the investigation of serum levels of vitamin D3 forms and their relative ratios in COVID-19 patients is worth investigation to understand the impacts of disease severity. Hence, we investigated the serum levels of vitamin D3 (cholecalciferol) and its metabolites (calcifediol and calcitriol), in addition to their relative ratios and correlations with angiotensin-converting enzyme 2 (ACE2), interleukin-6 (Il-6), and neutrophil-lymphocyte ratio (NLR) in COVID-19 patients compared with healthy controls. Oropharyngeal specimens were collected from the study subjects for polymerase chain reaction testing for COVID-19. Whole blood samples were obtained for blood count and NLR testing, and sera were used for the analysis of the levels of the vitamin and its metabolites, ACE2, and IL-6. We enrolled 103 patients and 50 controls. ACE2, Il-6, and NLR were significantly higher in the patients group (72.37 ± 18.67 vs. 32.36 ± 11.27 U/L, 95.84 ± 25.23 vs. 2.76 ± 0.62 pg/mL, and 1.61 ± 0.30 vs. 1.07 ± 0.16, respectively). Cholecalciferol, calcifediol, and calcitriol were significantly lower in patients (18.50 ± 5.36 vs. 29.13 ± 4.94 ng/mL, 14.60 ± 3.30 vs. 23.10 ± 3.02 ng/mL, and 42.90 ± 8.44 vs. 65.15 ± 7.11 pg/mL, respectively). However, their relative ratios were normal in both groups. Levels of the vitamin and metabolites were strongly positively, strongly negatively, and moderately negatively correlated with ACE2, Il-6, and NLR, respectively. COVID-19 infection severity is associated with a significant decrease in vitamin D3 and its metabolites in a parallel pattern, and with a significant increase in ACE2, Il-6, and NLR. Higher levels of vitamin D and its metabolites are potentially protective against severe infection.

Citing Articles

Assessment of Supplementation with Different Biomolecules in the Prevention and Treatment of COVID-19.

Gonzalez-Acedo A, Manzano-Moreno F, Garcia-Recio E, Ruiz C, De Luna-Bertos E, Costela-Ruiz V Nutrients. 2024; 16(18).

PMID: 39339670 PMC: 11434975. DOI: 10.3390/nu16183070.


Vitamin D Levels in COVID-19 and NonCOVID-19 Pediatric Patients and Its Relationship with Clinical and Laboratory Characteristics.

Totan M, Matacuta-Bogdan I, Hasegan A, Maniu I Biomedicines. 2024; 12(4).

PMID: 38672258 PMC: 11048677. DOI: 10.3390/biomedicines12040905.


The Impact of Serum Levels of Reactive Oxygen and Nitrogen Species on the Disease Severity of COVID-19.

Ahmed S, Alahmadi Y, Abdou Y Int J Mol Sci. 2023; 24(10).

PMID: 37240319 PMC: 10219364. DOI: 10.3390/ijms24108973.


Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial.

Bhat S, Das L, Maheshwari D, Badal D, Sarkar R, Gupta M J Infect. 2023; 86(5):e120-e122.

PMID: 36889512 PMC: 10008192. DOI: 10.1016/j.jinf.2023.03.004.

References
1.
Warner F, Rajapaksha H, Shackel N, Herath C . ACE2: from protection of liver disease to propagation of COVID-19. Clin Sci (Lond). 2020; 134(23):3137-3158. DOI: 10.1042/CS20201268. View

2.
Kuhn J, Li W, Choe H, Farzan M . Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus. Cell Mol Life Sci. 2004; 61(21):2738-43. PMC: 7079798. DOI: 10.1007/s00018-004-4242-5. View

3.
Munshi R, Hussein M, Toraih E, Elshazli R, Jardak C, Sultana N . Vitamin D insufficiency as a potential culprit in critical COVID-19 patients. J Med Virol. 2020; 93(2):733-740. DOI: 10.1002/jmv.26360. View

4.
Bartley J . Vitamin D: emerging roles in infection and immunity. Expert Rev Anti Infect Ther. 2010; 8(12):1359-69. DOI: 10.1586/eri.10.102. View

5.
Vanherwegen A, Gysemans C, Mathieu C . Regulation of Immune Function by Vitamin D and Its Use in Diseases of Immunity. Endocrinol Metab Clin North Am. 2017; 46(4):1061-1094. DOI: 10.1016/j.ecl.2017.07.010. View